West Pharmaceutical
230 hedge funds and large institutions have $3.04B invested in West Pharmaceutical in 2013 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 72 increasing their positions, 98 reducing their positions, and 12 closing their positions.
208% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 12
67% more funds holding in top 10
Funds holding in top 10: 6 → 10 (+4)
19% more capital invested
Capital invested by funds: $2.55B → $3.04B (+$486M)
12% more funds holding
Funds holding: 205 → 230 (+25)
27% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 98
34% less call options, than puts
Call options by funds: $344K | Put options by funds: $520K
87.6% less ownership
Funds ownership: 178.02% → 90.42% (-88%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$20.1M |
| 2 |
BAMCO Inc
New York
|
+$14.9M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.4M |
| 4 |
Neuberger Berman Group
New York
|
+$11.9M |
| 5 |
Renaissance Technologies
New York
|
+$11.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$32.1M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$22.1M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$11.6M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$9.87M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$9.11M |
WST Hedge Fund Activity: Q4 2013 in Review
230 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q4 2013, worth a combined $3.04B — up 19% from $2.55B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new WST positions and 12 closed out — a net gain of 25 holders — while 72 added to existing stakes and 98 trimmed.
The largest buyer was Northern Trust, adding an estimated $20.1M. The largest seller was Fidelity Investments, exiting entirely with an estimated $32.1M sold.
- 230 institutional investors held West Pharmaceutical (WST) as of Q4 2013, up from 205 in Q3 2013.
- Funds reported $3.04B of West Pharmaceutical stock for Q4 2013, up 19% quarter-over-quarter.
- 37 funds opened new West Pharmaceutical positions in Q4 2013 and 12 closed out, a net change of +25 holders.
- The largest West Pharmaceutical buyer in Q4 2013 was Northern Trust, an estimated $20.1M added.
- The largest West Pharmaceutical seller in Q4 2013 was Fidelity Investments, an estimated $32.1M sold.
Based on aggregated 13F filings for Q4 2013.